Engineered Whole Lungs for Tissue Biology
Greaney, A. M.; Raredon, M. S. B.; Obata, T.; Wang, J.; Adams, T. S.; Schupp, J. C.; Mizoguchi, S.; Edelstein, S.; Yuan, Y.; Baevova, P.; Wang, N.; Engler, A.; Leiby, K.; Tsuchiya, T.; Homer, R.; Kaminski, N.; Langer, R.; Niklason, L.; Medzhitov, R.
Show abstract
End-stage lung disease and lung cancer significantly contribute to global mortality, necessitating new research strategies for studying pulmonary biology. Here, we present an engineered whole-lung tissue model used to evaluate the effects of cellular communities on tissue organization and alveolar barrier function. Engineered lungs were grown ex vivo on decellularized whole-lung matrices as structurally biomimetic, bioactive scaffolds. Histologic architecture of engineered lungs improved with the addition of alveolar macrophages, coming to resemble neonatal lung. Incorporating alveolar macrophages maximized the differentiation of native-like cellular communities, including alveolar type I-like epithelium, bronchioalveolar stem cells, microvascular endothelium, and pericytes. Cell-cell signaling in engineered lungs showed activation of developmental and inflammatory pathways, including WNT, Notch, and FGF signaling pathways. Engineered lungs containing alveolar macrophages showed a 668% improvement in measured alveolar barrier function. This work demonstrates the potential utility of engineered lung models for studying principles of tissue biology and pulmonary regeneration.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.